Clinigen Group Stock Price, News & Analysis (LON:CLIN)

Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

Clinigen Group announced a dividend on Thursday, September 19th. Stockholders of record on Thursday, November 7th will be given a dividend of GBX 4.75 per share on Friday, November 29th. This represents a dividend yield of 0.51%. The ex-dividend date of this dividend is Thursday, November 7th. This is an increase from Clinigen Group's previous dividend of $1.95. The official announcement can be viewed at this link. View Clinigen Group's Dividend History.

Clinigen Group PLC (LON:CLIN) announced its earnings results on Tuesday, February, 27th. The company reported $21.20 earnings per share for the quarter, beating the consensus estimate of $20.30 by $0.90. The company earned $167.80 million during the quarter. View Clinigen Group's Earnings History.

5 brokerages have issued 1-year price targets for Clinigen Group's stock. Their forecasts range from GBX 1,000 to GBX 1,640. On average, they expect Clinigen Group's share price to reach GBX 1,295 in the next twelve months. This suggests a possible upside of 57.0% from the stock's current price. View Analyst Price Targets for Clinigen Group.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.

News headlines about CLIN stock have been trending negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Clinigen Group earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Clinigen Group.

Some companies that are related to Clinigen Group include Healthscope (HSO), SmileDirectClub (SDC), The Medicines (MDCO), Amedisys (AMED), Premier (PINC), Repligen (RGEN), Ascendis Pharma A/S (ASND), Healthequity (HQY), BTG (BTGGF), Spark Therapeutics (ONCE), Ablynx (ABLYF), GETINGE AB/ADR (GNGBY), Aurora Cannabis (ACB), ConvaTec Group (CTEC) and Ansell (ANN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Advanced Accelerator Application (AAAP), First Hawaiian (FHB), Landec (LNDC), NII (NIHD), Albemarle (ALB), RTI International Metals (RTI), NetApp (NTAP) and StatPro Group (SOG).

Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of CLIN stock can currently be purchased for approximately GBX 825.

Clinigen Group has a market capitalization of £1.09 billion and generates £456.90 million in revenue each year. Clinigen Group employs 849 workers across the globe.View Additional Information About Clinigen Group.

The official website for Clinigen Group is http://www.clinigengroup.com/.

Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.